Immunodiagnostic Systems Holdings PLC reported unaudited Group financial results for the six months ended 30 September 2020. For the six months, the group reported revenue of £13,698,000 against £18,791,000 for the same period of last year. Loss from operations was £3,540,000 against profit of £642,000 for the same period of last year. Loss for the period attributable to owners of the parent was £2,952,000 against profit of £16,000 for the same period of last year. Basic loss per share was 0.3 pence against profit of 0.1 pence for the same period of last year.